Cleared Traditional

K190722 - TriMAX Implant System

K190722 is the FDA 510(k) clearance for TriMAX Implant System by Crossroads Extemity Systems, LLC. It is a Class 2 Orthopedic device (product code JDR) cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K190722 · Crossroads Extemity Systems, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
149d
Days
Class 2
Risk

K190722 is an FDA 510(k) clearance for the TriMAX Implant System. Classified as Staple, Fixation, Bone (product code JDR), Class II - Special Controls.

Submitted by Crossroads Extemity Systems, LLC (Memphis, US). The FDA issued a Cleared decision on August 16, 2019 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3030 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Crossroads Extemity Systems, LLC devices

Submission Details

510(k) Number K190722 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 2019
Decision Date August 16, 2019
Days to Decision 149 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d slower than avg
Panel avg: 122d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JDR Staple, Fixation, Bone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3030
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Mrc X, LLC
Theresa Leister

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JDR Staple, Fixation, Bone

All 97
Devices cleared under the same product code (JDR) and FDA review panel - the closest regulatory comparables to K190722.
DynaClip Bone Staple
K193305 · MedShape, Inc. · Apr 2020
Superelastic Staple
K192447 · Neosteo · Feb 2020
DePuy Synthes Hammertoe Continuous Compression Implant
K191463 · Synthes USA Products, LLC · Feb 2020
APTUS Foot System
K191636 · Medartis AG · Aug 2019
TriMed Nitinol Staple System
K190166 · TriMed, Inc. · Jul 2019
VERTEX Nitinol Staple System
K182943 · Nvision Biomedical Technologies, LLC · Apr 2019